Category: Editorial - Psychedelic Alpha

Access exclusive insights, data and interviews with Pα+: learn more and subscribe today.

Read more about the article Numinus Deep Dive: Developing and Delivering Psychedelic-Assisted Psychotherapies

Numinus Deep Dive: Developing and Delivering Psychedelic-Assisted Psychotherapies

Post published:March 23, 2021
Post category:Analysis Editorial

Tryp Therapeutics Launches Clinical Trials to Investigate Psilocybin for Over-Eating Disorders

Post published:February 16, 2021
Post category:Analysis Editorial

Read more about the article The Psychedelic Renaissance in 2020

The Psychedelic Renaissance in 2020

Post published:December 30, 2020
Post category:Analysis Editorial

Read more about the article Cybin Corp Establishes a Firm Foothold in the Psychedelic Sector with Historic CAD$45 Million Raise

Cybin Corp Establishes a Firm Foothold in the Psychedelic Sector with Historic CAD$45 Million Raise

Post published:October 30, 2020
Post category:Analysis Editorial

Read more about the article Medical Marijuana as Precedent for Psychedelic Medicine; and the Role of Pharmacists

Medical Marijuana as Precedent for Psychedelic Medicine; and the Role of Pharmacists

Post published:August 14, 2020
Post category:Editorial

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.